Melanocytic nevus natural history: Difference between revisions
Mahshid |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Melanocytic nevus}} | |||
'''Editors-In-Chief:''' Martin I. Newman, M.D., FACS, Cleveland Clinic Florida, [mailto:Newmanm@ccf.org]; {{AE}} {{Qurrat}}; [[User:Mcs|Michel C. Samson, M.D., FRCSC, FACS]] [mailto:samsonm1@ccf.org] | |||
==Overview== | ==Overview== | ||
Revision as of 15:42, 23 April 2019
|
Melanocytic nevus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanocytic nevus natural history On the Web |
|
American Roentgen Ray Society Images of Melanocytic nevus natural history |
|
Risk calculators and risk factors for Melanocytic nevus natural history |
Editors-In-Chief: Martin I. Newman, M.D., FACS, Cleveland Clinic Florida, [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2]; Michel C. Samson, M.D., FRCSC, FACS [3]
Overview
Vast majority of moles are benign. Nonetheless, the National (U.S.) Cancer Institute reported 59,940 new cases of melanoma by June, 2007, with 8,110 deaths.[1]
Complications
Experts say that vast majority of moles are benign. Nonetheless, the National (U.S.) Cancer Institute reported 59,940 new cases of melanoma by June, 2007, with 8,110 deaths.[2]